FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022388410> ?p ?o ?g. }

• W3022388410 endingPage "1157" @default.
• W3022388410 startingPage "1157" @default.
• W3022388410 abstract "Tumour necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) is a promising anti-cancer agent that rapidly induces apoptosis in cancer cells. Unfortunately, the clinical application of recombinant TRAIL (rTRAIL) has been hampered by its common cancer resistance. Naturally TRAIL is delivered as a membrane-bound form by extracellular vesicles (EV-T) and is highly efficient for apoptosis induction. SCH727965 (dinaciclib), a potent cyclin-dependent kinase (CDK) inhibitor, was shown to synergize with other drugs to get better efficacy. However, it has never been investigated if dinaciclib coordinates with EV-T to enhance therapeutic results. This study explores the potential of combination therapy with EV-T and dinaciclib for cancer treatment. EV-T was successfully derived from human TRAIL transduced cells and shown to partially overcome resistance of A549 cells. Dinaciclib was shown to drastically enhance EV-T killing effects on cancer lines that express good levels of death receptor (DR) 5, which are associated with suppression of CDK1, CDK9 and anti-apoptotic proteins. Combination therapy with low doses of EV-T and dinaciclib induced strikingly enhanced apoptosis and led to complete regression in A549 tumors without any adverse side effects observed in a subcutaneous xenograft model. Tumor infiltration of mass NK cells and macrophages was also observed. These observations thus indicate that the combination of EV-T with dinaciclib is a potential novel therapy for highly effective and safe cancer treatment." @default.
• W3022388410 created "2020-05-13" @default.
• W3022388410 creator A5002675186 @default.
• W3022388410 creator A5005496050 @default.
• W3022388410 creator A5023962135 @default.
• W3022388410 creator A5044190108 @default.
• W3022388410 creator A5047806168 @default.
• W3022388410 creator A5060507935 @default.
• W3022388410 creator A5072864969 @default.
• W3022388410 creator A5075287546 @default.
• W3022388410 creator A5083770123 @default.
• W3022388410 creator A5088915238 @default.
• W3022388410 date "2020-05-04" @default.
• W3022388410 modified "2023-10-13" @default.
• W3022388410 title "Extracellular Vesicle Delivery of TRAIL Eradicates Resistant Tumor Growth in Combination with CDK Inhibition by Dinaciclib" @default.
• W3022388410 cites W1519516598 @default.
• W3022388410 cites W1542448731 @default.
• W3022388410 cites W1563016338 @default.
• W3022388410 cites W1662505552 @default.
• W3022388410 cites W1755000358 @default.
• W3022388410 cites W1840112861 @default.
• W3022388410 cites W1977514126 @default.
• W3022388410 cites W1978440559 @default.
• W3022388410 cites W1991054314 @default.
• W3022388410 cites W2007718868 @default.
• W3022388410 cites W2011326217 @default.
• W3022388410 cites W2017932620 @default.
• W3022388410 cites W2020316909 @default.
• W3022388410 cites W2022554737 @default.
• W3022388410 cites W2028640652 @default.
• W3022388410 cites W2035915920 @default.
• W3022388410 cites W2037289115 @default.
• W3022388410 cites W2038266165 @default.
• W3022388410 cites W2038530391 @default.
• W3022388410 cites W2046614846 @default.
• W3022388410 cites W2059150400 @default.
• W3022388410 cites W2068720118 @default.
• W3022388410 cites W2078217054 @default.
• W3022388410 cites W2084376588 @default.
• W3022388410 cites W2096185404 @default.
• W3022388410 cites W2098715950 @default.
• W3022388410 cites W2103880807 @default.
• W3022388410 cites W2104773756 @default.
• W3022388410 cites W2105825161 @default.
• W3022388410 cites W2129305290 @default.
• W3022388410 cites W2140642045 @default.
• W3022388410 cites W2166488783 @default.
• W3022388410 cites W2167445011 @default.
• W3022388410 cites W2169693674 @default.
• W3022388410 cites W2288895418 @default.
• W3022388410 cites W2291355594 @default.
• W3022388410 cites W2326577933 @default.
• W3022388410 cites W2345878988 @default.
• W3022388410 cites W2504613444 @default.
• W3022388410 cites W2584177434 @default.
• W3022388410 cites W2609866624 @default.
• W3022388410 cites W2753630019 @default.
• W3022388410 cites W2774269198 @default.
• W3022388410 cites W2783507731 @default.
• W3022388410 cites W2790751347 @default.
• W3022388410 cites W2799422921 @default.
• W3022388410 cites W2897132139 @default.
• W3022388410 cites W2900756811 @default.
• W3022388410 cites W2913596155 @default.
• W3022388410 cites W2925372744 @default.
• W3022388410 cites W2941347673 @default.
• W3022388410 cites W2950400468 @default.
• W3022388410 cites W2980870177 @default.
• W3022388410 cites W2990529806 @default.
• W3022388410 cites W2995128645 @default.
• W3022388410 cites W2996061352 @default.
• W3022388410 doi "https://doi.org/10.3390/cancers12051157" @default.
• W3022388410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7281120" @default.
• W3022388410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32375399" @default.
• W3022388410 hasPublicationYear "2020" @default.
• W3022388410 type Work @default.
• W3022388410 sameAs 3022388410 @default.
• W3022388410 citedByCount "24" @default.
• W3022388410 countsByYear W30223884102020 @default.
• W3022388410 countsByYear W30223884102021 @default.
• W3022388410 countsByYear W30223884102022 @default.
• W3022388410 countsByYear W30223884102023 @default.
• W3022388410 crossrefType "journal-article" @default.
• W3022388410 hasAuthorship W3022388410A5002675186 @default.
• W3022388410 hasAuthorship W3022388410A5005496050 @default.
• W3022388410 hasAuthorship W3022388410A5023962135 @default.
• W3022388410 hasAuthorship W3022388410A5044190108 @default.
• W3022388410 hasAuthorship W3022388410A5047806168 @default.
• W3022388410 hasAuthorship W3022388410A5060507935 @default.
• W3022388410 hasAuthorship W3022388410A5072864969 @default.
• W3022388410 hasAuthorship W3022388410A5075287546 @default.
• W3022388410 hasAuthorship W3022388410A5083770123 @default.
• W3022388410 hasAuthorship W3022388410A5088915238 @default.
• W3022388410 hasBestOaLocation W30223884101 @default.
• W3022388410 hasConcept C121608353 @default.
• W3022388410 hasConcept C124320809 @default.
• W3022388410 hasConcept C126322002 @default.
• W3022388410 hasConcept C185592680 @default.

• next